Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Morozova

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Haematology|March 25, 2026
Secondary Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome Following Allo-HCT: Features, Outcomes, and Risk StratificationNikita Volkov, Ivan Moiseev, Maria Krivitskaya, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 11, 2022
Toward a digital analysis of environmental impacts on rodent mammary gland density during critical developmental windowsAlina M Hamilton, Linnea T Olsson, Bentley R Midkiff, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|October 1, 2018
Engineering methionine γ-lyase from Citrobacter freundii for anticancer activitySamanta Raboni, Svetlana Revtovich, Nicola Demitri, et al.
Cancer|May 15, 2025
Allogeneic hematopoietic cell transplantation with a combination of posttransplantation bendamustine and cyclophosphamide in refractory myeloid neoplasmsIvan Moiseev, Sergey Bondarenko, Yulia Vlasova, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host DiseaseAndrey Kozlov, Maria Estrina, Olesia Paina, et al.
Molecular and Cellular Biochemistry|June 1, 2022
Dose-dependent effects of perfluorocarbon-based blood substitute on cardiac function in myocardial ischemia-reperfusion injuryVladimir Jakovljevic, Sergey Vorobyev, Sergey Bolevich, et al.
Transplantation and Cellular Therapy|April 12, 2021
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Bendamustine in Patients with Refractory Acute Leukemia: A Dose-Ranging StudyIvan Moiseev, Sergey Bondarenko, Elena Morozova, et al.
Frontiers in Oncology|April 3, 2023
Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experienceTamara Chitanava, Iuliia Matvienko, Vasily Shuvaev, et al.
Bone Marrow Transplantation|April 25, 2024
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, et al.
Bone Marrow Transplantation|October 2, 2021
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMTStavroula Masouridi-Levrat, Eduardo Olavarria, Simona Iacobelli, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Haematology|March 25, 2026
Secondary Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome Following Allo-HCT: Features, Outcomes, and Risk StratificationNikita Volkov, Ivan Moiseev, Maria Krivitskaya, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 11, 2022
Toward a digital analysis of environmental impacts on rodent mammary gland density during critical developmental windowsAlina M Hamilton, Linnea T Olsson, Bentley R Midkiff, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|October 1, 2018
Engineering methionine γ-lyase from Citrobacter freundii for anticancer activitySamanta Raboni, Svetlana Revtovich, Nicola Demitri, et al.
Cancer|May 15, 2025
Allogeneic hematopoietic cell transplantation with a combination of posttransplantation bendamustine and cyclophosphamide in refractory myeloid neoplasmsIvan Moiseev, Sergey Bondarenko, Yulia Vlasova, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host DiseaseAndrey Kozlov, Maria Estrina, Olesia Paina, et al.
Molecular and Cellular Biochemistry|June 1, 2022
Dose-dependent effects of perfluorocarbon-based blood substitute on cardiac function in myocardial ischemia-reperfusion injuryVladimir Jakovljevic, Sergey Vorobyev, Sergey Bolevich, et al.
Transplantation and Cellular Therapy|April 12, 2021
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Bendamustine in Patients with Refractory Acute Leukemia: A Dose-Ranging StudyIvan Moiseev, Sergey Bondarenko, Elena Morozova, et al.
Frontiers in Oncology|April 3, 2023
Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experienceTamara Chitanava, Iuliia Matvienko, Vasily Shuvaev, et al.
Bone Marrow Transplantation|April 25, 2024
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, et al.
Bone Marrow Transplantation|October 2, 2021
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMTStavroula Masouridi-Levrat, Eduardo Olavarria, Simona Iacobelli, et al.
Pageof 6